AstraZeneca
AZN
#63
Rank
$218.70 B
Marketcap
$70.54
Share price
-0.14%
Change (1 day)
-11.13%
Change (1 year)

AstraZeneca (AZN) - Cash on Hand

Cash on Hand as of March 2025 : $5.39 Billion USD

According to AstraZeneca's latest financial reports the company has $5.39 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AstraZeneca - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$5.65 B-3.52%
2023-12-31$5.86 B-6.13%
2022-12-31$6.24 B-2.42%
2021-12-31$6.39 B-19.94%
2020-12-31$7.99 B28.55%
2019-12-31$6.21 B11.14%
2018-12-31$5.59 B22.84%
2017-12-31$4.55 B-21.63%
2016-12-31$5.81 B-13.82%
2015-12-31$6.74 B-4.23%
2014-12-31$7.04 B-28.84%
2013-12-31$9.89 B20.32%
2012-12-31$8.22 B-27.08%
2011-12-31$11.27 B-4.64%
2010-12-31$11.82 B3.71%
2009-12-31$11.40 B159.67%
2008-12-31$4.39 B-26.3%
2007-12-31$5.95 B-22.46%
2006-12-31$7.68 B54.33%
2005-12-31$4.97 B-5.43%
2004-12-31$5.26 B33.26%
2003-12-31$3.95 B-15.72%
2002-12-31$4.68 B22.63%
2001-12-31$3.82 B-14.14%
2000-12-31$4.45 B35.41%
1999-12-31$3.28 B-3.63%
1998-12-31$3.41 B183.13%
1997-12-31$1.20 B-27.82%
1996-12-31$1.66 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bristol-Myers Squibb
BMY
$11.78 B 118.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$17.31 B 220.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$9.22 B 71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$5.79 B 7.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
$8.64 B 60.25%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
$3.22 B-40.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$38.78 B 618.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$6.84 B 26.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$2.59 B-51.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$7.19 B 33.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland